NeuroMetrix, Inc. (NASDAQ:NURO) Sees Large Increase in Short Interest

NeuroMetrix, Inc. (NASDAQ:NURO) was the recipient of a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 28,100 shares, an increase of 24.3% from the August 15th total of 22,600 shares. Currently, 1.8% of the company’s shares are short sold. Based on an average daily volume of 15,200 shares, the short-interest ratio is presently 1.8 days.

NeuroMetrix Trading Up 0.7 %

Shares of NURO stock traded up $0.03 on Tuesday, reaching $4.05. 19,001 shares of the company’s stock were exchanged, compared to its average volume of 27,372. The company’s fifty day simple moving average is $3.61 and its 200 day simple moving average is $3.84. NeuroMetrix has a 52 week low of $2.66 and a 52 week high of $6.00. The stock has a market capitalization of $8.14 million, a PE ratio of -0.64 and a beta of 2.28.

NeuroMetrix (NASDAQ:NURO) last released its earnings results on Tuesday, August 6th. The medical device company reported ($0.74) earnings per share for the quarter. The business had revenue of $0.77 million for the quarter. NeuroMetrix had a negative return on equity of 41.74% and a negative net margin of 181.04%.

Analyst Ratings Changes

Separately, StockNews.com began coverage on shares of NeuroMetrix in a research report on Tuesday. They issued a “sell” rating on the stock.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.